Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

GSK-364735

Catalog No. T68517Cas No. 863434-13-3
Alias S-364735, S364735, S/GSK-364735, S/GSK364735, GSK364735

GSK-364735 is a human immunodeficiency virus type 1 integrase (HIV-1 IN) inhibitor with antiviral activity and is used in the study of retroviral infections.

GSK-364735

GSK-364735

Purity: 97.89%
Catalog No. T68517Alias S-364735, S364735, S/GSK-364735, S/GSK364735, GSK364735Cas No. 863434-13-3
GSK-364735 is a human immunodeficiency virus type 1 integrase (HIV-1 IN) inhibitor with antiviral activity and is used in the study of retroviral infections.
Pack SizePriceAvailabilityQuantity
25 mg$1,520In Stock
50 mg$1,980In Stock
100 mg$2,500In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:97.89%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
GSK-364735 is a human immunodeficiency virus type 1 integrase (HIV-1 IN) inhibitor with antiviral activity and is used in the study of retroviral infections.
Targets&IC50
HIV-1:8 nM
In vitro
GSK-364735 is a potent anti-human immunodeficiency virus type 1 (HIV-1) drug that inhibits viral integrase with an inhibitory half concentration (IC50) of 8 nM. [1]
AliasS-364735, S364735, S/GSK-364735, S/GSK364735, GSK364735
Chemical Properties
Molecular Weight371.36
FormulaC19H18FN3O4
Cas No.863434-13-3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GSK-364735 | purchase GSK-364735 | GSK-364735 cost | order GSK-364735 | GSK-364735 chemical structure | GSK-364735 in vitro | GSK-364735 formula | GSK-364735 molecular weight